Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiya Horimoto

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Anticancer Research|April 4, 2021
Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast CancerRitsuko Sasaki, Yoshiya Horimoto, Yuka Yanai, et al.
Breast Cancer (Tokyo, Japan)|July 29, 2020
Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-upYuko Yoshida-Ichikawa, Yoshiya Horimoto, Naoto Shikama, et al.
The Journal of Obstetrics and Gynaecology Research|July 16, 2019
Usefulness of immunohistochemistry for mismatch repair protein and microsatellite instability examination in adenocarcinoma and background endometrium of sporadic endometrial cancer casesHarumi Saeki, May T Hlaing, Yoshiya Horimoto, et al.
Surgical Case Reports|November 5, 2025
A Case of Breast Cancer with Cystic Axillary Lymph Node MetastasisMariko Yoshino, Yoshiya Horimoto, Mutsumi Hayashi, et al.
Cancer Diagnosis & Prognosis|July 2, 2025
Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter StudyMahana Iwai, Yoshiya Horimoto, Rongrong Wu, et al.
Surgical Case Reports|November 7, 2024
Granulomatous mastitis forming a well-defined large mass diagnosed by surgical excision: a case reportChisaki Hao, Yoshiya Horimoto, Toshitaka Uomori, et al.
Juntendo Iji Zasshi = Juntendo Medical Journal|July 18, 2024
Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance SystemRitsuko Sasaki, Yoshiya Horimoto, Harumi Saeki, et al.
Cancer Science|July 25, 2022
Involvement of kallikrein-PAR2-proinflammatory pathway in severe trastuzumab-induced cardiotoxicityRitsuko Sasaki, Nagomi Kurebayashi, Hidetaka Eguchi, et al.
International Journal of Surgical Pathology|May 9, 2023
Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the BreastMen Yuan, Harumi Saeki, Yoshiya Horimoto, et al.
Surgical Case Reports|March 23, 2023
Acute myocarditis during adjuvant therapies for breast cancer: a case reportYumiko Ushiyama, Yoshiya Horimoto, Toshitaka Uomori, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Anticancer Research|April 4, 2021
Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast CancerRitsuko Sasaki, Yoshiya Horimoto, Yuka Yanai, et al.
Breast Cancer (Tokyo, Japan)|July 29, 2020
Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-upYuko Yoshida-Ichikawa, Yoshiya Horimoto, Naoto Shikama, et al.
The Journal of Obstetrics and Gynaecology Research|July 16, 2019
Usefulness of immunohistochemistry for mismatch repair protein and microsatellite instability examination in adenocarcinoma and background endometrium of sporadic endometrial cancer casesHarumi Saeki, May T Hlaing, Yoshiya Horimoto, et al.
Surgical Case Reports|November 5, 2025
A Case of Breast Cancer with Cystic Axillary Lymph Node MetastasisMariko Yoshino, Yoshiya Horimoto, Mutsumi Hayashi, et al.
Cancer Diagnosis & Prognosis|July 2, 2025
Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter StudyMahana Iwai, Yoshiya Horimoto, Rongrong Wu, et al.
Surgical Case Reports|November 7, 2024
Granulomatous mastitis forming a well-defined large mass diagnosed by surgical excision: a case reportChisaki Hao, Yoshiya Horimoto, Toshitaka Uomori, et al.
Juntendo Iji Zasshi = Juntendo Medical Journal|July 18, 2024
Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance SystemRitsuko Sasaki, Yoshiya Horimoto, Harumi Saeki, et al.
Cancer Science|July 25, 2022
Involvement of kallikrein-PAR2-proinflammatory pathway in severe trastuzumab-induced cardiotoxicityRitsuko Sasaki, Nagomi Kurebayashi, Hidetaka Eguchi, et al.
International Journal of Surgical Pathology|May 9, 2023
Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the BreastMen Yuan, Harumi Saeki, Yoshiya Horimoto, et al.
Surgical Case Reports|March 23, 2023
Acute myocarditis during adjuvant therapies for breast cancer: a case reportYumiko Ushiyama, Yoshiya Horimoto, Toshitaka Uomori, et al.
Pageof 13